Authors Boland CR, Bigler J, Newcomb PA, et al. Citation Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2285-6; author reply 2286. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15598796/ PMCID NA
Association between biallelic and monoallelic germline MYH mutations and colorectal cancer risk.
Authors Croitoru ME, Cleary SP, Di Nicola N, et al. Citation J Natl Cancer Inst. 2004;96(21):1631-4. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15523092/ PMCID NA
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.
Authors Doria-Rose VP, Levin TR, Selby JV, et al. Citation Gastroenterology. 2004; 127:714-722. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15362026/ PMCID NA
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
Authors Kambara T, Simms LA, Whitehall VL, et al. Citation Gut. 2004 Aug;53(8):1137-44. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15247181/ PMCID PMC1774130
Role of inherited defects of MYH in the development of sporadic colorectal cancer.
Authors Kambara T, Whitehall VL, Spring KJ, et al. Citation Genes Chromosomes Cancer. 2004 May;40(1):1-9. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15034862/ PMCID NA
Colorectal tumour microsatellite instability test results: perspectives from patients.
Authors Lindor NM, Sloan J, Goldberg R, et al. Citation Hered Cancer Clin Pract. 2004 May 15;2(2):69-75. PubMedLink https://pubmed.ncbi.nlm.nih.gov/20233473/ PMCID PMC2839997
Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes.
Authors Lindor NM. Citation Clin Gastroenterol Hepatol. 2004 May;2(5):366-75. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15118973/ PMCID NA
Reasons given by relatives of colorectal cancer patients for not undergoing screening.
Authors Madlensky L, Esplen MJ, Goel V. Citation Prev Med. 2004 Oct;39(4):643-8. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15351528/ PMCID NA
No evidence of an association of JC virus and colon neoplasia.
Authors Newcomb PA, Bush AC, Stoner GL, et al. Citation Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):662-6. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15066935/ PMCID NA
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.
Authors Pepe MS, Janes H, Longton G, et al. Citation Am J Epidemiol. 2004 May 1;159(9):882-90. PubMedLink https://pubmed.ncbi.nlm.nih.gov/15105181/ PMCID NA